Insights on the Renal Biomarkers Global Market to 2027 - by Biomarker Type, Diagnostic Technique, End-user and Region - ResearchAndMarkets.com
Retrieved on:
Friday, June 17, 2022
Health, Biotechnology, Chronic kidney disease, Metabolomics, GFR, Industry, Mortality, COVID-19, Urine test strip, Genomics, Glomerular filtration rate, Gene, Non-communicable disease, Proteomics, Blood urea nitrogen, Acute kidney injury, Hospital, Lipid, Growth, Disease, Hypertension, Protein, AKI, SCR, ADPKD, CKD, MicroRNA, Biomarker, Degenerative disease, HIV disease progression rates, Diagnosis, Cell, BUN, Transplant glomerulopathy, Risk, Diabetes, Pharmaceutical industry, Medical imaging, Potash
As they also aid in predicting disease progression and computing drug dosage, renal biomarkers find extensive applications in hospitals and diagnostic laboratories across the globe.
Key Points:
- As they also aid in predicting disease progression and computing drug dosage, renal biomarkers find extensive applications in hospitals and diagnostic laboratories across the globe.
- How has the global renal biomarkers market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global renal biomarkers market?
- What is the structure of the global renal biomarkers market and who are the key players?